{
  "guid": "http://www.wnyc.org/story/bad-medicine-part-2-drug-trials-and-tribulations/",
  "title": "269. Bad Medicine, Part 2: (Drug) Trials and Tribulations",
  "description": "<p>How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on \"dream patients\" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.</p>\n",
  "pubDate": "Thu, 8 Dec 2016 04:00:00 +0000",
  "author": "editor@freakonomics.com (Freakonomics Radio + Stitcher)",
  "link": "http://freakonomics.com/",
  "content:encoded": "<p>How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on \"dream patients\" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.</p>\n",
  "enclosure": "",
  "itunes:title": "269. Bad Medicine, Part 2: (Drug) Trials and Tribulations",
  "itunes:author": "Freakonomics Radio + Stitcher",
  "itunes:image": "",
  "itunes:duration": "00:45:22",
  "itunes:summary": "How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on \"dream patients\" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.",
  "itunes:subtitle": "How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on \"dream patients\" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.",
  "itunes:explicit": "no",
  "itunes:episodeType": "full"
}